Courses & Units

Advanced Pharmacotherapeutics in Cardiovascular Diseases CSA722

Hobart

Introduction

CSA722 is a self-directed, fully on-line unit, that explores a variety of disease states and their management, using a series of patient cases linked to assignment based questions, to enable the student to enhance their knowledge in the area of clinical pharmacy and pharmaceutical care.

Summary

Unit name Advanced Pharmacotherapeutics II
Unit code CSA722
Credit points 12.5
College/School College of Health and Medicine
School of Pharmacy and Pharmacology
Discipline Pharmacy
Coordinator Doctor Mohammed Salahudeen
Teaching staff Miss Jacqueline Martin
Available as student elective? No
Delivered By Delivered wholly by the provider
Level Postgraduate

Availability

This unit is currently unavailable.

Note

Please check that your computer meets the minimum System Requirements if you are attending via Distance/Off-Campus.

Units are offered in attending mode unless otherwise indicated (that is attendance is required at the campus identified). A unit identified as offered by distance, that is there is no requirement for attendance, is identified with a nominal enrolment campus. A unit offered to both attending students and by distance from the same campus is identified as having both modes of study.

Key Dates

Study Period Start date Census date WW date End date
Semester 1 22/2/2021 23/3/2021 12/4/2021 30/5/2021
Semester 2 12/7/2021 10/8/2021 30/8/2021 17/10/2021

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (see withdrawal dates explained for more information).

Unit census dates currently displaying for 2021 are indicative and subject to change. Finalised census dates for 2021 will be available from the 1st October 2020. Note census date cutoff is 11.59pm AEST (AEDT during October to March).

About Census Dates

Learning Outcomes

  • Identify and evaluate problems associated with cardiovascular medicines using an evidence-based approach.
  • Critically evaluate cardiovascular medication therapy using an evidence-based approach and accepted best clinical practice to devise and justify appropriate courses of action for therapeutic management.
  • Employ evidence-based and contemporary clinical skills to conduct a clinical audit and demonstrate how this may influence pharmacy practice in the management of cardiovascular disease.
  • Demonstrate effective written and oral presentation skills to explain contemporary issues associated with cardiovascular medication therapy
Field of Education Commencing Student Contribution 1 Grandfathered Student Contribution 1 Approved Pathway Course Student Contribution 2 Domestic Full Fee
019907 $993.00 $993.00 not applicable $2,354.00
  • Available as a Commonwealth Supported Place
  • HECS-HELP is available on this unit, depending on your eligibility3
  • FEE-HELP is available on this unit, depending on your eligibility4

1 Please refer here more information on student contribution amounts.
2 Information on eligibility and Approved Pathway courses can be found here
3 Please refer here for eligibility for HECS-HELP
4 Please refer here for eligibility for FEE-HELP

If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.

Please note: international students should refer to this page to get an indicative course cost.

Requisites

Concurrent Prerequisites

CSA721

Teaching

Teaching Pattern

Online via MyLO and Online tutorial and meeting rooms.

AssessmentTest or quiz (5%)|Presentation (20%)|Assignment (15%)|Case Study (25%)|Case Study (35%)
TimetableView the lecture timetable | View the full unit timetable

Textbooks

Required

Required readings will be listed in the unit outline prior to the start of classes.

LinksBooktopia textbook finder

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.